Xanodyne's drug for menstrual bleeding gains FDA approval

11/16/2009 | MSNBC

The FDA approved Xanodyne Pharmaceuticals' Lysteda as a treatment for heavy menstrual bleeding. The agency cautioned patients about using the product in combination with hormonal contraceptives because of a high risk of blood clots, stroke and heart attack.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA